Correlates of death among SARS-CoV-2 positive veterans: The contribution of lifetime tobacco use.
Black or African American
/ statistics & numerical data
Age Factors
Aged
COVID-19
/ mortality
Endocrine System Diseases
/ epidemiology
Female
Hospitals, Veterans
Humans
Immunologic Deficiency Syndromes
/ epidemiology
Lung Diseases
/ epidemiology
Male
Middle Aged
Retrospective Studies
Risk Factors
Sex Factors
Smoking
/ epidemiology
Tobacco Use
/ epidemiology
United States
/ epidemiology
Veterans
/ statistics & numerical data
White People
/ statistics & numerical data
COVID-19
Lifetime tobacco use
Mortality
SARS-CoV-2
Veterans
Journal
Addictive behaviors
ISSN: 1873-6327
Titre abrégé: Addict Behav
Pays: England
ID NLM: 7603486
Informations de publication
Date de publication:
02 2021
02 2021
Historique:
received:
23
07
2020
revised:
15
09
2020
accepted:
29
09
2020
pubmed:
26
10
2020
medline:
1
1
2021
entrez:
25
10
2020
Statut:
ppublish
Résumé
Despite a growing body of research examining correlates and consequences of COVID-19, few findings have been published among military veterans. This limitation is particularly concerning as preliminary data indicate that veterans may experience a higher rate of mortality compared to their civilian counterparts. One factor that may contribute to increased rates of death among veterans with COVID-19 is tobacco use. Indeed, findings from a recent meta-analysis highlight the association between lifetime smoking status and COVID-19 progression to more severe or critical conditions including death. Notably, prevalence rates of tobacco use are higher among veterans than civilians. Thus, the purpose of the current study was to examine demographic and medical variables that may contribute to likelihood of death among veterans testing positive for SARS-CoV-2. Additionally, we examined the unique influence of lifetime tobacco use on veteran mortality when added to the complete model. Retrospective chart reviews were conducted on 440 veterans (80.5% African American/Black) who tested positive for SARS-CoV-2 (7.3% deceased) at a large, southeastern Veterans Affairs (VA) hospital between March 11, 2020 and April 23, 2020, with data analysis occurring from May 26, 2020 to June 5, 2020. Older age, male gender, immunodeficiency, endocrine, and pulmonary diseases were positively related to the relative risk of death among SARS-CoV-2 positive veterans, with lifetime tobacco use predicting veteran mortality above and beyond these variables. Findings highlight the importance of assessing for lifetime tobacco use among SARS-CoV-2 positive patients and the relative importance of lifetime tobacco use as a risk factor for increased mortality.
Identifiants
pubmed: 33099250
pii: S0306-4603(20)30822-4
doi: 10.1016/j.addbeh.2020.106692
pmc: PMC7538383
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
106692Subventions
Organisme : NIGMS NIH HHS
ID : U54 GM104940
Pays : United States
Informations de copyright
Published by Elsevier Ltd.
Références
Lancet Respir Med. 2020 Apr;8(4):420-422
pubmed: 32085846
Eur J Neurol. 2018 Jan;25(1):120-127
pubmed: 28960663
MMWR Morb Mortal Wkly Rep. 2020 Apr 03;69(13):382-386
pubmed: 32240123
BMC Bioinformatics. 2011 Mar 17;12:77
pubmed: 21414208
Psychosom Med. 2004 May-Jun;66(3):411-21
pubmed: 15184705
Am J Prev Med. 2012 Nov;43(5):483-9
pubmed: 23079170
Nicotine Tob Res. 2020 Aug 24;22(9):1653-1656
pubmed: 32399563
Eur J Intern Med. 2020 May;75:107-108
pubmed: 32192856
JAMA. 2020 May 26;323(20):2052-2059
pubmed: 32320003
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Arch Intern Med. 2000 Nov 27;160(21):3252-7
pubmed: 11088086
Inflammation. 2011 Aug;34(4):231-7
pubmed: 20625922